𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Progress in Alzheimer’s disease

✍ Scribed by Daniela Galimberti; Elio Scarpini

Book ID
106095416
Publisher
Springer
Year
2011
Tongue
English
Weight
223 KB
Volume
259
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progression in alzheimer's disease: Sequ
Progression in alzheimer's disease: Sequencing of neuropsychological decline
✍ Ove Almkvist; Lars Bäckman 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB

## Abstract The progression of cognitive and motor functions in Alzheimer's disease (AD) patients and healthy aged individuals was studied. For the healthy aged, the progress was negligible during a 2‐year period. In the AD patients, there was a marked progression in all cognitive tests, but only a

Memory rehabilitation in Alzheimer's dis
Memory rehabilitation in Alzheimer's disease: a review of progress
✍ Luc P. De Vreese; Mirco Neri; Mario Fioravanti; Luciano Belloi; Orazio Zanetti 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

## Background: Memory rehabilitation is a sadly misrepresented area of applied research in alzheimer's disease. ## Objectives: To gather and evaluate recent evidence for the clinical effectiveness or ecologically validity of memory rehabilitation for mild to moderate alzheimer's patients. ## Met

Primary progressive aphasia—differentiat
Primary progressive aphasia—differentiation from Alzheimer's disease
✍ M-Marchsel Mesulam 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

In 1982, I described six patients who experienced a gradually worsening aphasia without the additional manifestations of dementia [lo}. Language abilities deteriorated relentlessly whereas most other cognitive and behavioral functions appeared relatively spared. Upon quantitative neuropsychological

Measurement of progression in Alzheimer'
Measurement of progression in Alzheimer's disease: a clinician's perspective
✍ Douglas J. Gelb 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 2 views

Patients with Alzheimer's disease (AD) and their families must confront two fundamental truths. First, AD is a uniformly progressive disease that ultimately results in debilitating cognitive impairment. Second, although there is now evidence that some medications may produce transient improvement or